News
The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...
The issuer is solely responsible for the content of this announcement.
The FDA is phasing out animal testing for monoclonal antibody therapies, embracing AI and human-based models. Read more here.
5h
AZoRobotics on MSNFujitsu and Headwaters Trial On-Device Generative AI Solution to Streamline JAL Cabin Crew WorkflowsFujitsu Limited and AI solutions provider Headwaters Co., Ltd. today announced the successful completion of field trials ...
The obvious result of the legal shootout between the U.S. Food & Drug Administration (FDA) and clinical laboratory trade associations, the American Clinical Laboratory Association and the Association ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results